Q20
Conditions
Interventions
Group 1: The inspiratory resistance training will be performed with the device POWERbreathe (Fa. GAIAM, Ltd.). Patients breathe through the device and feel resistance at inhalation. At the beginning
Sponsors
Deutsches Herzzentrum München
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Univentricular Heart Fontan physiology
Exclusion criteria
Exclusion criteria: Change in drug administration in the last 3 months Cardiac catheter examination in the last 6 months Heart surgery in the last 12 months Planned intervention in the near future Neuromuscular disease Moderate to severe ventricular dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in physical capacity after 6 months of supervised inspiratory training: Based on cardiopulmonary exercise tests the maximal oxygen uptake (peak VO2) will be evaluated at baseline and after 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in ventilation-perfusion mismatch: VE/VCO2 slope from a cardiopulmonary exercise test Changes in lung volumes (FVC, FEV1) at spirometry Change in quality of life: SF-36 quality of life (Questionary) Change in tissue oxygenation: near infrared spectroscopy Change in the autonomic nervous system: Heart rate variability In addition, those patients with ventilatory training will be examined again after 6 months of unsupervised training. Those patients randomized to the control group will receive supervised ventilatory training after their 6 months control, another evaluation after that 6 months of supervised training and a fourth evaluation after 6 months of unsupervised training. | — |
Countries
Germany
Contacts
Public ContactCelina Fritz
Deutsches Herzzentrum München
Outcome results
None listed